BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer
Tomohiro Kubo(Sapporo Medical University), Junji Kato(Hokkaido Sapporo Kiyota High School)
Cited by 23
Related Papers
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
|Scientific Reports|2019|155
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
|Blood Advances|2021|109
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan
|Journal of Gastroenterology|2004|63